JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB84766

Recombinant Human Tau383 protein

Recombinant Human Tau383 protein

Be the first to review this product! Submit a review

|

(0 Publication)

Recombinant Human Tau383 protein is a Human Full Length protein, in the 1 to 383 aa range, expressed in Escherichia coli, with >90%, suitable for SDS-PAGE, WB.

別名を表示する

MAPTL, MTBT1, TAU, MAPT, Microtubule-associated protein tau, Neurofibrillary tangle protein, Paired helical filament-tau, PHF-tau

1 Images
SDS-PAGE - Recombinant Human Tau383 protein (AB84766)
  • SDS-PAGE

Unknown

SDS-PAGE - Recombinant Human Tau383 protein (AB84766)

SDS-PAGE showing ab84766 at approximately 52kDa.

Key facts

精製度

>90% Densitometry

発現系

Escherichia coli

タグ

Tag free

アプリケーション

WB, SDS-PAGE

applications

生物活性

No

アクセッション番号

P10636

アニマルフリー

No

キャリアフリー

No

Human

バッファー組成

pH: 7.5 Constituents: 25% Glycerol (glycerin, glycerine), 0.87% Sodium chloride, 0.79% Tris HCl, 0.00385% (R*,R*)-1,4-Dimercaptobutan-2,3-diol, 0.00174% PMSF

storage-buffer

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "SDS-PAGE": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" }, "WB": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

配列情報

[{"sequence":"","proteinLength":"Full Length","predictedMolecularWeight":null,"actualMolecularWeight":null,"aminoAcidEnd":383,"aminoAcidStart":1,"nature":"Recombinant","expressionSystem":null,"accessionNumber":"P10636","tags":[]}]

出荷温度及び保存条件

出荷温度
Dry Ice
短期保存温度
-80°C
長期保存温度
-80°C
分注に関する情報
Upon delivery aliquot
保管に関する情報
Avoid freeze / thaw cycle
False

補足情報

This supplementary information is collated from multiple sources and compiled automatically.

Tau383 also known as Microtubule-associated protein tau isoform 383 is a protein with a molecular mass of approximately 45 kDa. It plays an important role in stabilizing microtubules which are components of the cytoskeleton essential for maintaining cell structure and facilitating intracellular transport. Tau383 is characterized by its ability to bind to and promote the polymerization of tubulin into microtubules. It is predominantly expressed in neurons particularly in axons where it regulates the dynamic stability of microtubules essential for efficient neuronal function.
Biological function summary

Tau383 contributes to cellular processes related to the maintenance of neuronal structure and function. It acts as a microtubule-associated protein within the axonal cytoskeleton network. This protein does not typically form complexes but its interaction with microtubules is important for their assembly and stabilization. Alterations in its expression or post-translational modifications can significantly impact microtubule function and neuronal health.

Pathways

Tau383 plays an important role in the microtubule regulation pathways that are vital for axonal transport and cytoskeletal dynamics. It is closely associated with kinases and phosphatases such as glycogen synthase kinase 3 beta (GSK3β) and protein phosphatase 2A (PP2A) which regulate its phosphorylation state. The phosphorylation of Tau383 affects its ability to bind to microtubules influencing the pathways that are fundamental for synaptic plasticity and neuronal development.

Tau383 is particularly implicated in neurodegenerative conditions such as Alzheimer's disease and frontotemporal dementia. Abnormal hyperphosphorylation of Tau383 leads to the formation of neurofibrillary tangles a hallmark of Alzheimer's pathology. This process involves altered interactions with proteins like amyloid-beta whereby Tau383 aggregation exacerbates neuronal damage and cognitive decline in these disorders. Consequently Tau383 is a significant target for therapeutic interventions aiming to alleviate tau-related pathologies in neurodegenerative diseases.

製品の性状

製品の状態

Liquid

一般的な情報

機能

Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed : 21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed : 21985311, PubMed : 32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.

翻訳後修飾

Phosphorylation at serine and threonine residues in S-P or T-P motifs by proline-directed protein kinases (PDPK1, CDK1, CDK5, GSK3, MAPK) (only 2-3 sites per protein in interphase, seven-fold increase in mitosis, and in the form associated with paired helical filaments (PHF-tau)), and at serine residues in K-X-G-S motifs by MAP/microtubule affinity-regulating kinase (MARK1, MARK2, MARK3 or MARK4), causing detachment from microtubules, and their disassembly (PubMed:23666762, PubMed:7706316). Phosphorylation decreases with age. Phosphorylation within tau/MAP's repeat domain or in flanking regions seems to reduce tau/MAP's interaction with, respectively, microtubules or plasma membrane components (PubMed:7706316). Phosphorylation on Ser-610, Ser-622, Ser-641 and Ser-673 in several isoforms during mitosis. Phosphorylation at Ser-548 by GSK3B reduces ability to bind and stabilize microtubules. Phosphorylation at Ser-579 by BRSK1 and BRSK2 in neurons affects ability to bind microtubules and plays a role in neuron polarization. Phosphorylated at Ser-554, Ser-579, Ser-602, Ser-606 and Ser-669 by PHK. Phosphorylation at Ser-214 by SGK1 mediates microtubule depolymerization and neurite formation in hippocampal neurons. There is a reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces glycosylation by a factor of 2 and 4 respectively. Phosphorylation on Ser-721 is reduced by about 41.5% by GlcNAcylation on Ser-717. Dephosphorylated at several serine and threonine residues by the serine/threonine phosphatase PPP5C.. Polyubiquitinated. Requires functional TRAF6 and may provoke SQSTM1-dependent degradation by the proteasome (By similarity). PHF-tau can be modified by three different forms of polyubiquitination. 'Lys-48'-linked polyubiquitination is the major form, 'Lys-6'-linked and 'Lys-11'-linked polyubiquitination also occur.. O-glycosylated. O-GlcNAcylation content is around 8.2%. There is reciprocal down-regulation of phosphorylation and O-GlcNAcylation. Phosphorylation on Ser-717 completely abolishes the O-GlcNAcylation on this site, while phosphorylation on Ser-713 and Ser-721 reduces O-GlcNAcylation by a factor of 2 and 4 respectively. O-GlcNAcylation on Ser-717 decreases the phosphorylation on Ser-721 by about 41.5%.. Glycation of PHF-tau, but not normal brain TAU/MAPT. Glycation is a non-enzymatic post-translational modification that involves a covalent linkage between a sugar and an amino group of a protein molecule forming ketoamine. Subsequent oxidation, fragmentation and/or cross-linking of ketoamine leads to the production of advanced glycation endproducts (AGES). Glycation may play a role in stabilizing PHF aggregation leading to tangle formation in AD.

製品プロトコール

ターゲットの情報

Promotes microtubule assembly and stability, and might be involved in the establishment and maintenance of neuronal polarity (PubMed : 21985311). The C-terminus binds axonal microtubules while the N-terminus binds neural plasma membrane components, suggesting that tau functions as a linker protein between both (PubMed : 21985311, PubMed : 32961270). Axonal polarity is predetermined by TAU/MAPT localization (in the neuronal cell) in the domain of the cell body defined by the centrosome. The short isoforms allow plasticity of the cytoskeleton whereas the longer isoforms may preferentially play a role in its stabilization.
See full target information MAPT

Abcam product promise

当社は、高品質な試薬を通じてお客様の研究を力強くサポートすることをお約束いたします。ご使用いただく各段階で、常にお客様をサポートできる体制を整えております。万が一、製品が期待通りに機能しない場合は、「Abcam Product Promise」による当社保証制度に基づき、安心してご利用いただけます。
保証に関する詳細については利用規約をご確認ください。

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com